Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Bone Neoplasms × pegylated granulocyte colony-stimulating factor × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1 Lymphoid 1 Breast 1

Conditions

Lymphoma 4 Breast Neoplasms 4 Uterine Cervical Neoplasms 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Ovarian Neoplasms 1 Neutropenia 1 Multiple Myeloma 1 Malignant Solid Tumors 1 Lymphoma, Non-Hodgkin 1 Hematologic Neoplasms 1 Breastcancer 1 Bone Neoplasms 1

Interventions

Ibandronic Acid 2 pegylated granulocyte colony-stimulating factor 1 Zoledronic Acid 1 Pregabalin 1 Kyphoplasty 1 Enoxaparin 1 Aspirin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02905916 2016-09-19

The Efficacy and Safety of PEG-rhG-CSF in Neutropenia After Chemotherapy

Peking University

Phase 4 Unknown

BreastLymphoidSarcoma

Bone Neoplasms, Breast Neoplasms, Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡